Asia-Pacific OTC Drug Market Report 2017
In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast), including
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast), including
- China
- Japan
- South Korea
- Taiwan
- India
- Southeast Asia
- Australia
- Bayer HealthCare
- GlaxoSmithKline (GSK)
- Johnson&Johnson
- Pfizer
- Sanofi
- AstraZeneca
- BioGaia
- Bristol Myers Squibb
- Bukwang Pharmaceutica
- Chr. Hansen
- Cipla
- CoLucid
- Daiichi Sankyo
- Friggs
- DSM
- Eisai
- Eli Lilly
- Herbalife
- Euradite
- Class A
- Class B
- Hospital
- Clinic
- Household
Asia-Pacific OTC Drug Market Report 2017
1 OTC DRUG OVERVIEW
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug by Product Category
1.2.1 Asia-Pacific OTC Drug Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Class A
1.2.4 Class B
1.3 Asia-Pacific OTC Drug Market by Application/End Users
1.3.1 Asia-Pacific OTC Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Asia-Pacific OTC Drug Market by Region
1.4.1 Asia-Pacific OTC Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of OTC Drug (2012-2022)
1.5.1 Asia-Pacific OTC Drug Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific OTC Drug Revenue and Growth Rate (2012-2022)
2 ASIA-PACIFIC OTC DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION
2.1 Asia-Pacific OTC Drug Market Competition by Players/Suppliers
2.1.1 Asia-Pacific OTC Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific OTC Drug (Volume and Value) by Type
2.2.1 Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific OTC Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific OTC Drug (Volume) by Application
2.4 Asia-Pacific OTC Drug (Volume and Value) by Region
2.4.1 Asia-Pacific OTC Drug Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific OTC Drug Revenue and Market Share by Region (2012-2017)
3 CHINA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
3.1 China OTC Drug Sales and Value (2012-2017)
3.1.1 China OTC Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 China OTC Drug Revenue and Growth Rate (2012-2017)
3.1.3 China OTC Drug Sales Price Trend (2012-2017)
3.2 China OTC Drug Sales Volume and Market Share by Type
3.3 China OTC Drug Sales Volume and Market Share by Application
4 JAPAN OTC DRUG (VOLUME, VALUE AND SALES PRICE)
4.1 Japan OTC Drug Sales and Value (2012-2017)
4.1.1 Japan OTC Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan OTC Drug Revenue and Growth Rate (2012-2017)
4.1.3 Japan OTC Drug Sales Price Trend (2012-2017)
4.2 Japan OTC Drug Sales Volume and Market Share by Type
4.3 Japan OTC Drug Sales Volume and Market Share by Application
5 SOUTH KOREA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
5.1 South Korea OTC Drug Sales and Value (2012-2017)
5.1.1 South Korea OTC Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea OTC Drug Revenue and Growth Rate (2012-2017)
5.1.3 South Korea OTC Drug Sales Price Trend (2012-2017)
5.2 South Korea OTC Drug Sales Volume and Market Share by Type
5.3 South Korea OTC Drug Sales Volume and Market Share by Application
6 TAIWAN OTC DRUG (VOLUME, VALUE AND SALES PRICE)
6.1 Taiwan OTC Drug Sales and Value (2012-2017)
6.1.1 Taiwan OTC Drug Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan OTC Drug Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan OTC Drug Sales Price Trend (2012-2017)
6.2 Taiwan OTC Drug Sales Volume and Market Share by Type
6.3 Taiwan OTC Drug Sales Volume and Market Share by Application
7 INDIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
7.1 India OTC Drug Sales and Value (2012-2017)
7.1.1 India OTC Drug Sales Volume and Growth Rate (2012-2017)
7.1.2 India OTC Drug Revenue and Growth Rate (2012-2017)
7.1.3 India OTC Drug Sales Price Trend (2012-2017)
7.2 India OTC Drug Sales Volume and Market Share by Type
7.3 India OTC Drug Sales Volume and Market Share by Application
8 SOUTHEAST ASIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
8.1 Southeast Asia OTC Drug Sales and Value (2012-2017)
8.1.1 Southeast Asia OTC Drug Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia OTC Drug Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia OTC Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia OTC Drug Sales Volume and Market Share by Type
8.3 Southeast Asia OTC Drug Sales Volume and Market Share by Application
9 AUSTRALIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
9.1 Australia OTC Drug Sales and Value (2012-2017)
9.1.1 Australia OTC Drug Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia OTC Drug Revenue and Growth Rate (2012-2017)
9.1.3 Australia OTC Drug Sales Price Trend (2012-2017)
9.2 Australia OTC Drug Sales Volume and Market Share by Type
9.3 Australia OTC Drug Sales Volume and Market Share by Application
10 ASIA-PACIFIC OTC DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
10.1 Bayer HealthCare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 OTC Drug Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline (GSK)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 OTC Drug Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Johnson&Johnson
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 OTC Drug Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 OTC Drug Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Sanofi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 OTC Drug Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 AstraZeneca
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 OTC Drug Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 BioGaia
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 OTC Drug Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Bristol Myers Squibb
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 OTC Drug Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Bukwang Pharmaceutica
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 OTC Drug Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Chr. Hansen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 OTC Drug Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Cipla
10.12 CoLucid
10.13 Daiichi Sankyo
10.14 Friggs
10.15 DSM
10.16 Eisai
10.17 Eli Lilly
10.18 Herbalife
10.19 Euradite
11 OTC DRUG MANUFACTURING COST ANALYSIS
11.1 OTC Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of OTC Drug
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 OTC Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
12.4 Downstream Buyers
13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 MARKET EFFECT FACTORS ANALYSIS
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 ASIA-PACIFIC OTC DRUG MARKET FORECAST (2017-2022)
15.1 Asia-Pacific OTC Drug Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific OTC Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific OTC Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific OTC Drug Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific OTC Drug Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific OTC Drug Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific OTC Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific OTC Drug Sales Forecast by Application (2017-2022)
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 OTC DRUG OVERVIEW
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug by Product Category
1.2.1 Asia-Pacific OTC Drug Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Class A
1.2.4 Class B
1.3 Asia-Pacific OTC Drug Market by Application/End Users
1.3.1 Asia-Pacific OTC Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Asia-Pacific OTC Drug Market by Region
1.4.1 Asia-Pacific OTC Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of OTC Drug (2012-2022)
1.5.1 Asia-Pacific OTC Drug Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific OTC Drug Revenue and Growth Rate (2012-2022)
2 ASIA-PACIFIC OTC DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION
2.1 Asia-Pacific OTC Drug Market Competition by Players/Suppliers
2.1.1 Asia-Pacific OTC Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific OTC Drug (Volume and Value) by Type
2.2.1 Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific OTC Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific OTC Drug (Volume) by Application
2.4 Asia-Pacific OTC Drug (Volume and Value) by Region
2.4.1 Asia-Pacific OTC Drug Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific OTC Drug Revenue and Market Share by Region (2012-2017)
3 CHINA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
3.1 China OTC Drug Sales and Value (2012-2017)
3.1.1 China OTC Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 China OTC Drug Revenue and Growth Rate (2012-2017)
3.1.3 China OTC Drug Sales Price Trend (2012-2017)
3.2 China OTC Drug Sales Volume and Market Share by Type
3.3 China OTC Drug Sales Volume and Market Share by Application
4 JAPAN OTC DRUG (VOLUME, VALUE AND SALES PRICE)
4.1 Japan OTC Drug Sales and Value (2012-2017)
4.1.1 Japan OTC Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan OTC Drug Revenue and Growth Rate (2012-2017)
4.1.3 Japan OTC Drug Sales Price Trend (2012-2017)
4.2 Japan OTC Drug Sales Volume and Market Share by Type
4.3 Japan OTC Drug Sales Volume and Market Share by Application
5 SOUTH KOREA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
5.1 South Korea OTC Drug Sales and Value (2012-2017)
5.1.1 South Korea OTC Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea OTC Drug Revenue and Growth Rate (2012-2017)
5.1.3 South Korea OTC Drug Sales Price Trend (2012-2017)
5.2 South Korea OTC Drug Sales Volume and Market Share by Type
5.3 South Korea OTC Drug Sales Volume and Market Share by Application
6 TAIWAN OTC DRUG (VOLUME, VALUE AND SALES PRICE)
6.1 Taiwan OTC Drug Sales and Value (2012-2017)
6.1.1 Taiwan OTC Drug Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan OTC Drug Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan OTC Drug Sales Price Trend (2012-2017)
6.2 Taiwan OTC Drug Sales Volume and Market Share by Type
6.3 Taiwan OTC Drug Sales Volume and Market Share by Application
7 INDIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
7.1 India OTC Drug Sales and Value (2012-2017)
7.1.1 India OTC Drug Sales Volume and Growth Rate (2012-2017)
7.1.2 India OTC Drug Revenue and Growth Rate (2012-2017)
7.1.3 India OTC Drug Sales Price Trend (2012-2017)
7.2 India OTC Drug Sales Volume and Market Share by Type
7.3 India OTC Drug Sales Volume and Market Share by Application
8 SOUTHEAST ASIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
8.1 Southeast Asia OTC Drug Sales and Value (2012-2017)
8.1.1 Southeast Asia OTC Drug Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia OTC Drug Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia OTC Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia OTC Drug Sales Volume and Market Share by Type
8.3 Southeast Asia OTC Drug Sales Volume and Market Share by Application
9 AUSTRALIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)
9.1 Australia OTC Drug Sales and Value (2012-2017)
9.1.1 Australia OTC Drug Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia OTC Drug Revenue and Growth Rate (2012-2017)
9.1.3 Australia OTC Drug Sales Price Trend (2012-2017)
9.2 Australia OTC Drug Sales Volume and Market Share by Type
9.3 Australia OTC Drug Sales Volume and Market Share by Application
10 ASIA-PACIFIC OTC DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
10.1 Bayer HealthCare
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 OTC Drug Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline (GSK)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 OTC Drug Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Johnson&Johnson
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 OTC Drug Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Pfizer
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 OTC Drug Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Sanofi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 OTC Drug Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 AstraZeneca
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 OTC Drug Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 BioGaia
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 OTC Drug Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Bristol Myers Squibb
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 OTC Drug Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Bukwang Pharmaceutica
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 OTC Drug Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Chr. Hansen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 OTC Drug Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Cipla
10.12 CoLucid
10.13 Daiichi Sankyo
10.14 Friggs
10.15 DSM
10.16 Eisai
10.17 Eli Lilly
10.18 Herbalife
10.19 Euradite
11 OTC DRUG MANUFACTURING COST ANALYSIS
11.1 OTC Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of OTC Drug
12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
12.1 OTC Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
12.4 Downstream Buyers
13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 MARKET EFFECT FACTORS ANALYSIS
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 ASIA-PACIFIC OTC DRUG MARKET FORECAST (2017-2022)
15.1 Asia-Pacific OTC Drug Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific OTC Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific OTC Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific OTC Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific OTC Drug Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia OTC Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific OTC Drug Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific OTC Drug Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific OTC Drug Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific OTC Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific OTC Drug Sales Forecast by Application (2017-2022)
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of OTC Drug
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Class A Product Picture
Figure Class B Product Picture
Figure Asia-Pacific OTC Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of OTC Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Household Examples
Table Key Downstream Customer in Household
Figure Asia-Pacific OTC Drug Market Size (Million USD) by Region (2012-2022)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific OTC Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific OTC Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific OTC Drug Sales Share by Players/Suppliers
Figure Asia-Pacific OTC Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific OTC Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific OTC Drug Revenue Share by Players
Figure 2017 Asia-Pacific OTC Drug Revenue Share by Players
Table Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of OTC Drug by Type (2012-2017)
Figure Asia-Pacific OTC Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific OTC Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Figure Asia-Pacific OTC Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of OTC Drug by Region (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Region in 2016
Table Asia-Pacific OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of OTC Drug by Region (2012-2017)
Figure Asia-Pacific OTC Drug Revenue Market Share by Region in 2016
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific OTC Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Application (2012-2017)
Figure China OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Type in 2016
Table China OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Application in 2016
Figure Japan OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Type in 2016
Table Japan OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Application in 2016
Figure South Korea OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea OTC Drug Sales Volume Market Share by Type in 2016
Table South Korea OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea OTC Drug Sales Volume Market Share by Application in 2016
Figure Taiwan OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan OTC Drug Sales Volume Market Share by Type in 2016
Table Taiwan OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan OTC Drug Sales Volume Market Share by Application in 2016
Figure India OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Type in 2016
Table India OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Application in 2016
Figure Australia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia OTC Drug Sales Volume Market Share by Type in 2016
Table Australia OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia OTC Drug Sales Volume Market Share by Application in 2016
Table Bayer HealthCare OTC Drug Basic Information List
Table Bayer HealthCare OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer HealthCare OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson&Johnson OTC Drug Basic Information List
Table Johnson&Johnson OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson&Johnson OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson&Johnson OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer OTC Drug Basic Information List
Table Pfizer OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi OTC Drug Basic Information List
Table Sanofi OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca OTC Drug Basic Information List
Table AstraZeneca OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table BioGaia OTC Drug Basic Information List
Table BioGaia OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioGaia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioGaia OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure BioGaia OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol Myers Squibb OTC Drug Basic Information List
Table Bristol Myers Squibb OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol Myers Squibb OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bukwang Pharmaceutica OTC Drug Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Chr. Hansen OTC Drug Basic Information List
Table Chr. Hansen OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chr. Hansen OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Chr. Hansen OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Chr. Hansen OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Cipla OTC Drug Basic Information List
Table CoLucid OTC Drug Basic Information List
Table Daiichi Sankyo OTC Drug Basic Information List
Table Friggs OTC Drug Basic Information List
Table DSM OTC Drug Basic Information List
Table Eisai OTC Drug Basic Information List
Table Eli Lilly OTC Drug Basic Information List
Table Herbalife OTC Drug Basic Information List
Table Euradite OTC Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2016
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific OTC Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific OTC Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Region in 2022
Figure China OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific OTC Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific OTC Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific OTC Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of OTC Drug
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Class A Product Picture
Figure Class B Product Picture
Figure Asia-Pacific OTC Drug Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of OTC Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Household Examples
Table Key Downstream Customer in Household
Figure Asia-Pacific OTC Drug Market Size (Million USD) by Region (2012-2022)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific OTC Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific OTC Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific OTC Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific OTC Drug Sales Share by Players/Suppliers
Figure Asia-Pacific OTC Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific OTC Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific OTC Drug Revenue Share by Players
Figure 2017 Asia-Pacific OTC Drug Revenue Share by Players
Table Asia-Pacific OTC Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of OTC Drug by Type (2012-2017)
Figure Asia-Pacific OTC Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific OTC Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Figure Asia-Pacific OTC Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific OTC Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of OTC Drug by Region (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Region in 2016
Table Asia-Pacific OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific OTC Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of OTC Drug by Region (2012-2017)
Figure Asia-Pacific OTC Drug Revenue Market Share by Region in 2016
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific OTC Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific OTC Drug Sales Market Share by Application (2012-2017)
Figure China OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Type in 2016
Table China OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table China OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Application in 2016
Figure Japan OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Type in 2016
Table Japan OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Application in 2016
Figure South Korea OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea OTC Drug Sales Volume Market Share by Type in 2016
Table South Korea OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea OTC Drug Sales Volume Market Share by Application in 2016
Figure Taiwan OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan OTC Drug Sales Volume Market Share by Type in 2016
Table Taiwan OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan OTC Drug Sales Volume Market Share by Application in 2016
Figure India OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Type in 2016
Table India OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Application in 2016
Figure Australia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Australia OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia OTC Drug Sales Volume Market Share by Type in 2016
Table Australia OTC Drug Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia OTC Drug Sales Volume Market Share by Application in 2016
Table Bayer HealthCare OTC Drug Basic Information List
Table Bayer HealthCare OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer HealthCare OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson&Johnson OTC Drug Basic Information List
Table Johnson&Johnson OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson&Johnson OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson&Johnson OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer OTC Drug Basic Information List
Table Pfizer OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi OTC Drug Basic Information List
Table Sanofi OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca OTC Drug Basic Information List
Table AstraZeneca OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table BioGaia OTC Drug Basic Information List
Table BioGaia OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioGaia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioGaia OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure BioGaia OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol Myers Squibb OTC Drug Basic Information List
Table Bristol Myers Squibb OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol Myers Squibb OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Bukwang Pharmaceutica OTC Drug Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Chr. Hansen OTC Drug Basic Information List
Table Chr. Hansen OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chr. Hansen OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Chr. Hansen OTC Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Chr. Hansen OTC Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Cipla OTC Drug Basic Information List
Table CoLucid OTC Drug Basic Information List
Table Daiichi Sankyo OTC Drug Basic Information List
Table Friggs OTC Drug Basic Information List
Table DSM OTC Drug Basic Information List
Table Eisai OTC Drug Basic Information List
Table Eli Lilly OTC Drug Basic Information List
Table Herbalife OTC Drug Basic Information List
Table Euradite OTC Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2016
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure Asia-Pacific OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific OTC Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific OTC Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific OTC Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Region in 2022
Figure China OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia OTC Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific OTC Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific OTC Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific OTC Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific OTC Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific OTC Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources